Academic Journal
Q1Cancer Letters
About Cancer Letters
Cancer Letters is a scholarly journal published by Elsevier Ireland Ltd. SCImago 2025 places it in Q1 with an SJR of 3.066 and an H-index of 240.
Its listed coverage is 1975-2026 and its research categories include Cancer Research (Q1); Oncology (Q1). The 2025 dataset reports 541 documents and 12959 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways, Diverse Scientific and Economic Studies, Human auditory perception and evaluation, RNA modifications and cancer, Carcinogens and Genotoxicity Assessment.
Recent Research Articles
Latest publications matched automatically by ISSN.
Tertiary lymphoid structures in hepatocellular carcinoma: Prognostic biomarker, immunotherapy predictor, and emerging therapeutic target
Mehriban Bazar, Ye Tian, Haijing Luan, Lin Zhang et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218798A Copper(I)-Azurin complex suppresses p53-mediated glycolysis to sensitize breast cancer to cuproptosis with MRI monitoring
Hui Wang, Yu Zhang, Dinghua Liu, Chang Liu et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218831Revisiting tumor vasculature in the era of cancer immunotherapy: from aberrant hallmark to therapeutic target
Xiang Fang, Fanqi Wang, Haiman Li, Ping Xiao et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218824PDX-Atlas: A web-based portal to manage and share data from patient-derived xenograft models of cancer
Shivakumar Keerthikumar, Ashlee K. Clark, Yuchen Wu, Bennett Anderson et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218836Lack of tumor-derived LCN2 sensitizes pancreatic cancer cells to ferroptosis induction
Valentina Pita-Grisanti, Kristyn Gumpper-Fedus, Claire Cornellier, Hsiang-Yin Hsueh et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218823ACSL5 drives pancreatic ductal adenocarcinoma by suppressing mitophagy and enhancing ferroptosis resistance via the JAK1-STAT1-OASL axis
Jingjing Dong, Mengting Dai, Yiming Zhou, Mengde Wu et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218809CD44-galectin-9 and TGF-β-Smad3 pathways form an autocrine loop which facilitates human cancer cells to self-regulate their immune evasion machinery
Xi Lei, Sibo Peng, Nijas Aliu, Rohanah Hussain et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218846Integrated analysis reveals the impact of obesity on triple-negative breast cancer
Peng Ji, Huai-liang Wu, Li-Hua He, Han Wang et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218833Epitranscriptomic silencing of STK25 promotes ferroptosis evasion via the METTL3–YAP–GPX4 axis in osteosarcoma
Zhuochao Liu, Zhusheng Zhang, Fangqiong Hu, Junxiang Wen et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218807Cancer-associated fibroblast-enriched TAGLN orchestrates HGF/c-MET-dependent transcriptional reprogramming in gastric cancer
Qiang Li, Jianing Yang, Luhong Cao, Qiushuang Wang et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218832XPO1 inhibition enhances the efficacy and durability of RAS-targeted therapy in preclinical models of KRASG12D mutant pancreatic ductal adenocarcinoma
Husain Yar Khan, Mohammed Najeeb Al Hallak, Amro Aboukameel, Sahar F. Bannoura et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218804Non-invasive strategy for gastric cancer detection: Integration of cell-free DNA fragmentomics and protein biomarkers
Yueqing Huang, Xuefei Xu, Nannan Jiang, Wei Zhang et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218811Preclinical evaluation of trastuzumab deruxtecan in a new HER2+ leptomeningeal colonization model
Dinesh Kumar, Vanesa Silvestri, Elijah F. Edmondson, Imran Khan et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218786Notch1 supports proliferation and bioenergetic activity in a pancreatic neuroendocrine neoplasm cell line
Steven D. Forsythe, Jasmine A. Watts, Yuvasri Golivi, James A. Mobley et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218800A human stem cell model of neuroblastoma identifies four chromosome 17q genes that drive tumor initiation and progression
Wanqi Fang, Bo Cheng, Steven Pastor, Michael J. Zobel et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218781Connexin-mediated regulation of nuclear activity in cancer: Direct and indirect mechanisms
Tânia Martins-Marques, Aldo Di Vito, Henrique Girão, Trond Aasen et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218837Complement C5a Fosters Tumor-promoting Immunity by Recruiting regulatory T cells in hepatocellular carcinoma
Run Huang, Tianhao Chu, Guiqi Zhu, Chenyang Tao et al.
2026-11 · DOI: 10.1016/j.canlet.2026.218818Aldo-keto reductase family 1 member C3 suppresses Glioma progression via inhibiting prostaglandin D2-dependent RhoA/ROCK signaling
Jie Wang, Huihao Ma, Baozhi Feng, Yan Fu et al.
2026-10 · DOI: 10.1016/j.canlet.2026.218705FGFR4 suppresses antitumor immunity and cuproptosis by disrupting CYLD-mediated stabilization of STING and FDX1
Hongguang Zhong, Ruixuan Huang, Wenyuan Deng, Ruiwen Ruan et al.
2026-10 · DOI: 10.1016/j.canlet.2026.218790Differential bioenergetic reprogramming driven by sorafenib reveals therapeutic vulnerabilities in biliary tract cancers
Wenhua Zhang, Beixuan He, Lei Zhang, Zixin Li et al.
2026-10 · DOI: 10.1016/j.canlet.2026.218700Reviews
Community Reviews
Version History
September 8, 2026 at 12:09 am
September 8, 2026